Report - CENA713DJP02 protocol ver3 - ClinicalTrials.gov · 2019. 5. 6. · [Exelon/Rivastigmine] Clinical Trial Protocol [CENA713DJP02] NCT02703636 [A 24-week, open-label, multicenter study

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form